DK0618962T3 - Thymidinphoshorylase til anvendelse ved modulering af cellulær proliferation eller kemotaxi - Google Patents
Thymidinphoshorylase til anvendelse ved modulering af cellulær proliferation eller kemotaxiInfo
- Publication number
- DK0618962T3 DK0618962T3 DK92922612T DK92922612T DK0618962T3 DK 0618962 T3 DK0618962 T3 DK 0618962T3 DK 92922612 T DK92922612 T DK 92922612T DK 92922612 T DK92922612 T DK 92922612T DK 0618962 T3 DK0618962 T3 DK 0618962T3
- Authority
- DK
- Denmark
- Prior art keywords
- thymidine phosphorylase
- cellular proliferation
- chemotaxis
- modulating cellular
- conjugate
- Prior art date
Links
- 101710132082 Pyrimidine/purine nucleoside phosphorylase Proteins 0.000 title abstract 5
- 102000013537 Thymidine Phosphorylase Human genes 0.000 title abstract 5
- 230000004663 cell proliferation Effects 0.000 title abstract 2
- 230000035605 chemotaxis Effects 0.000 title 1
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 abstract 1
- 241000588724 Escherichia coli Species 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000008685 targeting Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1048—Glycosyltransferases (2.4)
- C12N9/1077—Pentosyltransferases (2.4.2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
- A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
- A61K47/6811—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
- A61K47/6815—Enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB919121815A GB9121815D0 (en) | 1991-10-15 | 1991-10-15 | Medicine |
| PCT/GB1992/001887 WO1993008273A1 (en) | 1991-10-15 | 1992-10-15 | Thymidine phosphorylase for use in the modulation of cellular proliferation or chemotaxis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0618962T3 true DK0618962T3 (da) | 2001-10-01 |
Family
ID=10702923
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK92922612T DK0618962T3 (da) | 1991-10-15 | 1992-10-15 | Thymidinphoshorylase til anvendelse ved modulering af cellulær proliferation eller kemotaxi |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6290953B1 (da) |
| EP (1) | EP0618962B1 (da) |
| JP (1) | JP3532193B2 (da) |
| AT (1) | ATE202380T1 (da) |
| AU (1) | AU664865B2 (da) |
| CA (1) | CA2121358C (da) |
| DE (1) | DE69231891T2 (da) |
| DK (1) | DK0618962T3 (da) |
| ES (1) | ES2160098T3 (da) |
| GB (1) | GB9121815D0 (da) |
| GR (1) | GR3036647T3 (da) |
| WO (1) | WO1993008273A1 (da) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2474723A1 (en) * | 2002-01-28 | 2003-08-07 | Keraplast Technologies, Ltd. | Bioactive keratin peptides |
| GB201116767D0 (en) | 2011-09-28 | 2011-11-09 | St George S Hospital Medical School | Treatment for mitrochondrial neurogastrointestinal encephalomyopathy |
| KR101671361B1 (ko) * | 2016-08-08 | 2016-11-01 | 에스씨엠생명과학 주식회사 | TYMP(thymidine phosphorylase) 단백질을 유효성분으로 포함하는 탈모 예방 또는 치료용 약학적 조성물 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4178212A (en) * | 1975-01-27 | 1979-12-11 | Burroughs Wellcome Co. | Stabilized thymidine phosphorylase formulation |
| US4347315A (en) | 1980-04-25 | 1982-08-31 | Burroughs Wellcome Co. | Synthesis of ribosides using bacterial phosphorylase |
| JPS63280026A (ja) * | 1987-04-24 | 1988-11-17 | ザ ウエルカム フアウンデーション リミテッド | 抗ウイルス配合組成物 |
| US5227302A (en) * | 1988-12-20 | 1993-07-13 | Ludwig Institute For Cancer Research | DNA encoding platelet derived endothelial cell growth factor (PD-ECGF) |
| CA2005600A1 (en) * | 1988-12-20 | 1990-06-20 | Cal-Henrik Heldin | Endothelial cell growth factor |
| US5756686A (en) | 1988-12-20 | 1998-05-26 | Ludwig Institute For Cancer Research | Peptides derived from endothelial cell growth factor |
| US5314995A (en) * | 1990-01-22 | 1994-05-24 | Oncogen | Therapeutic interleukin-2-antibody based fusion proteins |
-
1991
- 1991-10-15 GB GB919121815A patent/GB9121815D0/en active Pending
-
1992
- 1992-10-15 AT AT92922612T patent/ATE202380T1/de not_active IP Right Cessation
- 1992-10-15 DK DK92922612T patent/DK0618962T3/da active
- 1992-10-15 JP JP50753193A patent/JP3532193B2/ja not_active Expired - Fee Related
- 1992-10-15 CA CA002121358A patent/CA2121358C/en not_active Expired - Fee Related
- 1992-10-15 DE DE69231891T patent/DE69231891T2/de not_active Expired - Fee Related
- 1992-10-15 WO PCT/GB1992/001887 patent/WO1993008273A1/en active IP Right Grant
- 1992-10-15 EP EP92922612A patent/EP0618962B1/en not_active Expired - Lifetime
- 1992-10-15 ES ES92922612T patent/ES2160098T3/es not_active Expired - Lifetime
- 1992-10-15 AU AU28728/92A patent/AU664865B2/en not_active Ceased
-
1996
- 1996-01-11 US US08/584,760 patent/US6290953B1/en not_active Expired - Fee Related
-
2001
- 2001-09-18 GR GR20010401505T patent/GR3036647T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| AU664865B2 (en) | 1995-12-07 |
| CA2121358C (en) | 2003-12-30 |
| JPH07501938A (ja) | 1995-03-02 |
| GB9121815D0 (en) | 1991-11-27 |
| JP3532193B2 (ja) | 2004-05-31 |
| DE69231891T2 (de) | 2002-03-28 |
| AU2872892A (en) | 1993-05-21 |
| DE69231891D1 (de) | 2001-07-26 |
| CA2121358A1 (en) | 1993-04-29 |
| GR3036647T3 (en) | 2001-12-31 |
| ES2160098T3 (es) | 2001-11-01 |
| US6290953B1 (en) | 2001-09-18 |
| EP0618962B1 (en) | 2001-06-20 |
| EP0618962A1 (en) | 1994-10-12 |
| WO1993008273A1 (en) | 1993-04-29 |
| ATE202380T1 (de) | 2001-07-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK463586A (da) | Fsh | |
| TR199700610A3 (tr) | Düsük molekül agirlikli çözünür, tümör nekroz faktörü tip-I ve tip-II proteinleri. | |
| ES2140082T3 (es) | Composiciones peptidicas con actividad de tipo factor de crecimiento. | |
| PT1017659E (pt) | Tetra-hidronaftalenos substituidos e compostos analogos | |
| DE69708121T2 (de) | Halogenid-enthaltende insulinzubereitungen | |
| DE69841015D1 (de) | Intrazelluläre herstellung von verkürztem hepatitis c-polypeptid e2 | |
| DK0851926T3 (da) | Varianter af humant rekombinant gamminterferon (rhu-IFN-gamma) med forøget termisk stabilitet | |
| ES2150233T3 (es) | Pirrolo(2,3-c)carbazol-6-onas condensadas que potencian la actividad de interferon gamma. | |
| AU8040898A (en) | Type-1 ribosome-inactivating protein | |
| HU9300397D0 (en) | Method for modifying tropism of micor-organisms to cells, tissues and host organisms recombinant micro-organisms obtained by this way and their application in human and veterinary medicine | |
| ATE183775T1 (de) | Cysteinfreie il-6 mutanten | |
| ES2150021T3 (es) | Derivados de acidos piridin- y pirazin-dicarboxilicos como reguladores de la proliferacion celular. | |
| DK0618962T3 (da) | Thymidinphoshorylase til anvendelse ved modulering af cellulær proliferation eller kemotaxi | |
| DK381189A (da) | N-2,3-butadienyl-tri- og -tetraaminoalkanderivater og deres anvendelse | |
| EP0154566A3 (en) | Viral enhancer dna segments | |
| ATE131175T1 (de) | Protein mit fibroblasten-wachstumsfaktor- rezeptoraktivität. | |
| AR011100A1 (es) | Adn obtenible de s. clavuligerus, vector que comprende dicho adn, organismo hospedador, s. clavuligerus, procedimiento para mejorar la produccion de5r-clavam en un microorganismo adecuado, microorganismo que tiene las facultades para la produccion de 5r-clavam y una produccion baja o nula de 5s- | |
| DE69605201D1 (de) | Erhaltung von schutzflächen auf kohlenstoff-kathoden in aluminium - elektrolyseofen | |
| DE69109615T2 (de) | Glatter Muskel Mitogen. | |
| Sherwood et al. | PRODUCTION OF HUMAN GROWTH HORMONE IN ESCHERICHIA COLI | |
| ES2138570A1 (es) | Procedimiento de utilizacion selectiva del herbicida imazetapir en post-emergencia del cultivo de variedades de girasol resistentes o tolerantes a este herbicida y su aplicacion en el control de la maleza parasita jopo (orobanche cernua loefl./ o. cumana waller). | |
| DE69825307D1 (de) | Verwendung von protein h als zytostattischer wirkstoff | |
| 小田光宏 | White, MD “Evaluation of the reference interview” | |
| IT1263041B (it) | Derivati di s,s'-bis(carbossammidofenil)-disolfuro ad attivita' cardiovascolare | |
| NO962468L (no) | Fremstilling og anvendelse av næringsgranulat |